Goldline Pharmaceutical Ltd IPO
SMEPrice Band
₹41-43
Issue Size
₹11.61 Cr
Lot Size
6000
Open Date
12 May 2026
Close Date
14 May 2026
Listing Date
19 May 2026
This IPO is Closed
Goldline Pharmaceutical Ltd IPO Timeline
Track key IPO dates — from opening and closing to allotment, refund, and listing.
IPO Open Date
12 May 2026
IPO Close Date
14 May 2026
Allotment Date
15 May 2026
Refund Date
18 May 2026
Credit to Demat
18 May 2026
Listing Date
19 May 2026
Goldline Pharmaceutical Ltd IPO Subscription Status
See how the issue is being subscribed across QIB, NII, Retail, and Employee categories.
| Date | QIB | NII | RII | Employee | Total |
|---|---|---|---|---|---|
| 12 May 2026 | 1.31x | 18.07x | 34.07x | 0.00x | 20.79x |
| 13 May 2026 | 1.31x | 108.19x | 139.51x | 0.00x | 93.19x |
| 14 May 2026 | 180.22x | 1227.90x | 881.15x | 0.00x | 781.85x |
Goldline Pharmaceutical Ltd IPO Financials
A quick look at revenue, EBITDA, profit, and net worth over the last three years.
| Year | Total Revenue (Cr) | EBITDA (Cr) | PAT (Cr) | Networth (Cr) | EPS (₹) |
|---|---|---|---|---|---|
| FY26-03 | 31.20 | 6.94 | 4.12 | 14.25 | 5.97 |
| FY25-03 | 28.06 | 5.83 | 2.83 | 10.35 | 4.11 |
| FY24-03 | 23.57 | 4.30 | 1.81 | 7.87 | 3.01 |
Goldline Pharmaceutical Ltd IPO Strengths
- Experienced promoters and management team with industry knowledge and a track record.
- Asset-light business model and competitive products.
- Scalable Business Model.
- Wide and diverse range of product offerings.
- Strong Supplier and Vendor Relationships.
- Established Distribution Network.
Goldline Pharmaceutical Ltd IPO Reservation
See what share of the issue is reserved for Retail, QIB, NII, and Anchor investors.
| Category | Shares Offered | % of Total |
|---|---|---|
| Retail | 9,00,000 | 33.33% |
| QIB | 5,40,000 | 20% |
| NII / HNI | 3,90,000 | 14.44% |
| Anchor Investors | 7,32,000 | 27.11% |
| Market Makers | 1,38,000 | 5.11% |
| Total | 27,00,000 | 100% |
Goldline Pharmaceutical Ltd Registrar & Company Details
Registrar
Bigshare Services Pvt Ltd
Office No S6-2, Pinnacle Busine.Park, Mahakali Caves Road, Mumbai - 400093
+91 22 6263 8200
ipo@bigshareonline.com
www.bigshareonline.com
Company
Goldline Pharmaceutical Ltd
103 F-1 Leela Apartment Shilpa, HSG Society Shanidham Narendra, Nagpur, 440015
+91 712 278 6666
info@goldlinepharma.in
CIN: U51397MH2004PLC147806
http://www.goldlinepharma.in
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
The Goldline Pharmaceutical Ltd IPO has an issue size of ₹11.61 crore.
The minimum investment required for the Goldline Pharmaceutical Ltd IPO is ₹2,58,000, based on a minimum lot size of 6000 shares and the applicable IPO price.
The lot size for the Goldline Pharmaceutical Ltd IPO is 6000 shares.
The allotment for the Goldline Pharmaceutical Ltd IPO is scheduled for 15 May 2026.
Investors can check the Goldline Pharmaceutical Ltd IPO allotment status using their PAN, application number, or other required details through the IPO registrar's website or the relevant stock exchange website.
The registrar for the Goldline Pharmaceutical Ltd IPO is Bigshare Services Pvt Ltd.
The Goldline Pharmaceutical Ltd IPO opens on 12 May 2026 and closes on 14 May 2026.
You can apply for the IPO through Anand Rathi using the applicable IPO application process:
Note: Investors are requested to do their own due diligence before investing in any IPO.
The Goldline Pharmaceutical Ltd IPO is scheduled to be listed on 19 May 2026 on BSE - SME.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
